KMT2A partial tandem duplications (PTD), most commonly involving exons 2 to 9, are observed in 10% of myelodysplastic syndrome/acute myeloid leukemia (MDS/AML) cases, and are associated with disease progression and relapse (39, 40). This evidence concerns the gene KMT2A and myelodysplastic syndrome.